The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas. “Although we support DEA’s efforts to combat diversion, we are concerned that the proposed rule is focused on diversion to the exclusion of another critical factor — drug shortages,” the AHA and other groups wrote. “To ensure that legitimate medical needs are met, it is imperative that drug shortages be considered as aggregate production quotas are set and adjusted.” The letter also was signed by the Ambulatory Surgical Center Association, American Society of Clinical Oncology, American Society of Health-System Pharmacists, American Society of Anesthesiologists, Federation of American Hospitals, and Institute for Safe Medication Practices. The AHA last week submitted its own letter to DEA urging the agency to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency's proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of injectable opioid medications.

Related News Articles

Headline
The Government Accountability Office yesterday released a report calling for the Department of Health and Human Services to improve its efforts responding to…
Chairperson's File
From making pizzas to leading an integrated health system, Tina Freese Decker’s career has focused on a connection to people and serving others. She is…
Blog
The AHA’s Institute for Diversity and Health Equity just wrapped up another distinguished year, where its work resonated with and celebrated AHA members and…
Headline
The AHA’s Institute for Diversity and Health Equity is seeking organizations to apply as host sites for its 2025 Summer Enrichment Program by Feb. 21. The…
Headline
The AHA Nov. 7 announced Claire M. Zangerle, DNP, R.N., as new senior vice president and chief nurse executive of the AHA and chief executive officer of its…
Headline
The AHA’s Institute for Diversity and Health Equity will host its next Health Equity Innovation Summit in Washington, D.C., on Nov. 12 from 9:30 a.m. to 3:30 p…